Risk factors and outcomes of cerebrospinal fluid overdrainage in HIV-negative patients with cryptococcal meningitis after the ventriculoperitoneal shunting procedure

J Microbiol Immunol Infect. 2018 Aug;51(4):545-551. doi: 10.1016/j.jmii.2017.06.002. Epub 2017 Jun 28.

Abstract

Purpose: Shunt procedures used to treat cryptococcal meningitis complicated with hydrocephalus and/or increased intracranial pressure (IICP) could result in cerebrospinal fluid (CSF) overdrainage, thereby presenting therapeutic challenges.

Methods: We analyzed the clinical features and neuroimaging findings after the ventriculoperitoneal (VP) shunt procedure in 51 HIV (Human Immunodeficiency Virus)-negative patients with cryptococcal meningitis, to assess the risk factors associated with post-shunt CSF overdrainage.

Results: Symptomatic CSF overdrainage occurred in 12% (6/51) of patients with cryptococcal meningitis who underwent the shunt procedure. Rapid deterioration of neurological conditions was found in 6 patients after the shunt procedure was performed, including disturbed consciousness, quadriparesis, and dysphasia in 5 patients and severe ataxia in 1. The mean duration of CSF overdrainage after the shunting procedure was 2-7 days (mean 4 days). The mean interval between meningitis onset to shunting procedure remained independently associated with CSF overdrainage, and the cut-off value for predicting CSF overdrainage in interval between meningitis onset to shunting procedure was 67.5 days.

Conclusions: CSF overdrainage after the VP shunt procedure is not rare, especially in patients with a high-risk of cryptococcal meningitis who also have a prolonged duration of hydrocephalus and/or IICP.

Keywords: CSF overdrainage; HIV-Negative cryptococcal meningitis; Outcome; Risk factor; Ventriculoperitoneal shunt procedures.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aphasia / epidemiology
  • Ataxia / epidemiology
  • Cognition Disorders / epidemiology
  • Female
  • Humans
  • Iatrogenic Disease / epidemiology*
  • Male
  • Meningitis, Cryptococcal / therapy*
  • Middle Aged
  • Quadriplegia / epidemiology
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Ventriculoperitoneal Shunt / adverse effects*
  • Young Adult